BAX•benzinga•
Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlook
Summary
Baxter International exceeded Q4 earnings and revenue estimates, with strong pharmaceutical sales. The company issued a mixed 2025 outlook amid cost pressures.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 20, 2025 by benzinga